- Home
- HOUR vs ESLA Comparison
HOUR vs ESLA Comparison
Compare HOUR & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- ESLA
- Stock Information
- Founded
- HOUR 2015
- ESLA 2021
- Country
- HOUR United States
- ESLA United States
- Employees
- HOUR N/A
- ESLA N/A
- Industry
- HOUR Catalog/Specialty Distribution
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOUR Consumer Discretionary
- ESLA Health Care
- Exchange
- HOUR Nasdaq
- ESLA Nasdaq
- Market Cap
- HOUR 43.2M
- ESLA 35.5M
- IPO Year
- HOUR 2022
- ESLA N/A
- Fundamental
- Price
- HOUR $1.29
- ESLA $1.04
- Analyst Decision
- HOUR
- ESLA Strong Buy
- Analyst Count
- HOUR 0
- ESLA 1
- Target Price
- HOUR N/A
- ESLA $16.00
- AVG Volume (30 Days)
- HOUR 24.8K
- ESLA 511.7K
- Earning Date
- HOUR 06-13-2025
- ESLA 06-17-2025
- Dividend Yield
- HOUR N/A
- ESLA N/A
- EPS Growth
- HOUR N/A
- ESLA N/A
- EPS
- HOUR 0.01
- ESLA N/A
- Revenue
- HOUR $139,408,829.00
- ESLA N/A
- Revenue This Year
- HOUR N/A
- ESLA $101.09
- Revenue Next Year
- HOUR N/A
- ESLA N/A
- P/E Ratio
- HOUR $186.13
- ESLA N/A
- Revenue Growth
- HOUR 2.71
- ESLA N/A
- 52 Week Low
- HOUR $0.83
- ESLA $0.63
- 52 Week High
- HOUR $6.90
- ESLA $3.23
- Technical
- Relative Strength Index (RSI)
- HOUR 46.39
- ESLA 47.74
- Support Level
- HOUR $1.22
- ESLA $0.78
- Resistance Level
- HOUR $1.34
- ESLA $1.18
- Average True Range (ATR)
- HOUR 0.08
- ESLA 0.08
- MACD
- HOUR 0.00
- ESLA -0.01
- Stochastic Oscillator
- HOUR 26.43
- ESLA 45.00
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.